Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 38.

Huber, M; Metzner, K J; Geissberger, F D; Shah, C; Leemann, C; Klimkait, T; Böni, J; Trkola, A; Zagordi, O (2017). MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing. Journal of Virological Methods, 240:7-13.

Weber, R; Huber, M; Battegay, M; Stähelin, C; Castro Batanjer, E; Calmy, A; Bregenzer, A; Bernasconi, E; Schoeni-Affolter, F; Ledergerber, B (2015). Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Medicine, 16(3):137-151.

Schmid, S; Grimm, F; Huber, M; Beck, B; Custer, P; Bode, B (2014). Taenia crassiceps infection - an unusual presentation of a tapeworm diagnosed by FNA cytology and PCR. Cytopathology, 25(5):340-341.

Wolfensberger, A; Huber, M; Choschzick, M; Mueller, N J (2014). Abdominale Tuberkulose. Der Gastroenterologe, 9(4):372-377.

Vrouenraets, S M E; Wit, F W N M; Garcia, E Fernandez; Huber, M; Brinkman, K; Moyle, G; Domingo, P; Tarr, P E; Podzamczer, D; Ristola, M; Gatell, J M; Livrozet, J M; Furrer, H; Reiss, P (2012). Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue. HIV Clinical Trials, 13(2):103-110.

Huber, M; Ledergerber, B; Sauter, R; Young, J; Fehr, J; Cusini, A; Battegay, M; Calmy, A; Orasch, C; Nicca, D; Bernasconi, E; Jaccard, R; Held, L; Weber, R (2012). Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV medicine, 13(7):387-397.

Antsiferova, M; Huber, M; Meyer, Michael; Piwko-Czuchra, A; Ramadan, T; MacLeod, A S; Havran, W L; Dummer, R; Hohl, D; Werner, S (2011). Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nature Communications, 2:576.

Guzek, M; Zorina, O I; Semmler, A; Gonzenbach, R R; Huber, M; Kullak-Ublick, G A; Weller, M; Russmann, S (2011). Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System). Pharmacoepidemiology and Drug Safety, 20(9):930-938.

Haueis, P; Greil, W; Huber, M; Grohmann, R; Kullak-Ublick, G A; Russmann, S (2011). Evaluation of drug interactions in a large sample of psychiatric inpatients: A data interface for mass analysis with clinical decision support software. Clinical Pharmacology and Therapeutics, 90(4):588-596.

Huber, M (2010). Compendium of bivalves. A full-color guide to 3,300 of the World’s Marine Bivalves. A status on Bivalvia after 250 years of research. Hackenheim D: ConchBooks.

Russmann, S; Curkovic, I; Huber, M (2010). Risiken und Nebenwirkungen durch Non Compliance. Therapeutische Umschau, 67(6):303-307.

Huber, M; Kovari, H; Weber, R; Meerbach, A (2010). Eine besondere Gelbsucht. Swiss Medical Forum, 10(25):450-451.

Huber, M (2010). Formal description and designation of holotypes for 23 bivalve species and type species for 2 bivalve genera (Mollusca: Bivalvia). Conchylia, 41(1):1-32.

Huber, M; Weber, R; Beck, B; Schweiger, A; Grimm, F (2010). Metastasenleber mit Eosinophilie. Swiss Medical Forum, 10(40):687-688.

Zeitz, J; Huber, M; Rogler, G (2010). Schwerer Verlauf einer Miliartuberkulose bei einem 34-jährigen Patienten mit Colitis ulcerosa und HIV-Infektion unter einer TNF-α-Antikörper-Therapie. Medizinische Klinik, 105(4):314-318.

Huber, M (2009). Name changes for two well-known Panamic Spondylis. Festivus, 41(7):103-109.

Huber, M; Kullak-Ublick, G A; Kirch, W (2009). Drug information for patients - an update of long-term results: type of enquiries and patient characteristics. Pharmacoepidemiology and Drug Safety, 18(2):111-119.

Huber, M; Kullak-Ublick, G A; Kirch, W (2009). 6 Jahre Erfahrungen mit einem Arzneimittelberatungsdienst für Patienten. Medizinische Klinik, 104(3):220-224.

Huber, M; Knönagel, H (2009). Der besondere Nierenstein. Swiss Medical Forum, 9(5):107-108.

Rusert, P; Mann, A; Huber, M; von Wyl, V; Gunthard, H F; Trkola, A (2009). Divergent effects of cell environment on HIV entry inhibitor activity. AIDS, 23(11):1319-1327.

Günthard, H F; Huber, M; Kuster, H; Shah, C; Schüpbach, J; Trkola, A; Böni, J (2009). HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia. Clinical Infectious Diseases, 48(11):e117-e120.

Cusini, A; Günthard, H F; Weber, R; Huber, M; Kamarashev, J; Bertisch, B; Peter, S; Beck, B (2009). Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy. BMJ Case Reports:bcr0520091904.

Isler, M; Huber, M; Günthard, H F; Böni, J (2009). Negativer HIV-Combitest trotz hoher HIV-1 Virämie bei einem Patienten mit akuter HIV-Infektion. Swiss Medical Forum, 9:87-88.

Huber, M; Schniebs, K (2009). The type specimens of recent molluscs described by ANTON (1837 and 1838): 8. Ostreidae, Cardiidae, Tellinidae, and Mactridae. Staatliches Museum für Tierkunde Dresden. Mollusca, 27(2):201-208.

Weber, R; Huber, M; Rickenbach, M; Furrer, H; Elzi, L; Hirschel, B; Cavassini, M; Bernasconi, E; Schmid, P; Ledergerber, B (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Medicine, 10(7):407-416.

Huber, M; Olson, W C; Trkola, A (2008). Antibodies for HIV treatment and prevention: window of opportunity? Current Topics in Microbiology and Immunology, 317:39-66.

Rehr, M; Cahenzli, J; Haas, A; Price, D A; Gostick, E; Huber, M; Karrer, U; Oxenius, A (2008). Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. Journal of Virology, 82(7):3391-3404.

Huber, M; Kullak-Ublick, G A (2008). Generika: Worauf sollte man beim Umstellen achten? Ars Medici, 16:1-5.

Huber, M; Kullak-Ublick, G A (2008). Generika: Worauf sollte man beim Umstellen achten? The Medical Journal (TMJ), 3:23-26.

Kreipl, K; Huber, M (2008). Mollusken aus Ghana. Club Conchylia Informationen, 39(3/4):60-64.

Huber, M; von Wyl, V; Ammann, C G; Kuster, H; Stiegler, G; Katinger, H; Weber, R; Fischer, M; Stoiber, H; Günthard, H F; Trkola, A (2008). Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked. Journal of Virology, 82(8):3834-3842.

Huber, M (2008). Strategie zur Ersttherapie. Suchtmedizin in Forschung und Praxis, 10(S1):18-29.

Fried, R; Monnat, M; Seidenberg, A; Oppliger, R; Schmid, P; Herold, M; Isler, M; Broers, B; Kölliker, C; Schönbucher, P; Frei, M; Huber, M (2008). Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs. Digestion, 78(2-3):123-130.

Geisler, R; Rauch, G J; Geiger-Rudolph, S; Albrecht, A J; van Bebber, F; Berger, A; Busch-Nentwich, E; Dahm, R; Dekens, M P S; Dooley, C; Elli, A F; Gehring, I; Geiger, H; Geisler, M; Glaser, S; Holley, S; Huber, M; Kerr, A; Kirn, A; Knirsch, M; Konantz, M; Küchler, A M; Maderspacher, F; Neuhauss, S C F; Nicolson, T; Ober, E A; Praeg, E; Ray, R; Rentzsch, B; Rick, J M; Rief, E; Schauerte, H E; Schepp, C P; Schönberger, U; Schonthaler, H B; Seiler, C; Sidi, S; Söllner, C; Wehner, A; Weiler, C; Nüsslein-Volhard, C (2007). Large-scale mapping of mutations affecting zebrafish development. BMC Genomics, 8:11.

Huber, M; Weber, R; Oppliger, R; Vernazza, P; Schmid, P; Schönbucher, P; Bertisch, B; Meili, D; Renner, E L (2005). Interferon alpha-2a Plus Ribavirin 1,000/1,200 mg versus Interferon alpha-2a Plus Ribavirin 600 mg for Chronic Hepatitis C Infection in Patients on Opiate Maintenance Treatment: An Open-Label Randomized Multicenter Trial. Infection, 33(1):25-29.

Koller, M F; Mohajeri, M H; Huber, M; Wollmer, M A; Roth Z'graggen, B V; Sandmeier, E; Moritz, E; Tracy, J; Nitsch, R M; Christen, P (2004). Active immunization of mice with an Abeta-Hsp70 vaccine. Neurodegenerative Diseases, 1(1):20-28.

Bahadori, R; Huber, M; Rinner, O; Seeliger, M W; Geiger-Rudolph, S; Geisler, R; Neuhauss, S C F (2003). Retinal function and morphology in two zebrafish models of oculo-renal syndromes. European Journal of Neuroscience, 18(6):1377-1386.

Brodmann, M; Huber, M; Kramer, J (2003). On the 100th anniversary of the birthday of J. J. Burckhardt (Zum 100. Geburtstag von J. J. Burckhardt). Elemente der Mathematik, 58(4):133.

This list was generated on Mon Jun 17 01:05:52 2019 CEST.